↓ Skip to main content

Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD)

Overview of attention for article published in this source, August 2010
Altmetric Badge

Mentioned by

blogs
3 blogs
policy
2 policy sources
facebook
1 Facebook page
wikipedia
1 Wikipedia page

Citations

dimensions_citation
126 Dimensions

Readers on

mendeley
138 Mendeley
citeulike
2 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD)
Published by
John Wiley & Sons, Ltd, August 2010
DOI 10.1002/14651858.cd004677.pub2
Pubmed ID
Authors

Williams, Katrina, Wheeler, Danielle M, Silove, Natalie, Hazell, Philip

Abstract

Autism spectrum disorders (ASD) are characterised by abnormalities in social interaction and communication skills, as well as stereotypic behaviours and restricted activities and interests. Selective serotonin reuptake inhibitors (SSRIs) are prescribed for the treatment of co-morbidity associated with ASD such as depression, anxiety and obsessive-compulsive behaviours.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 138 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 1%
Netherlands 1 <1%
Egypt 1 <1%
Unknown 134 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 21 15%
Student > Bachelor 18 13%
Student > Ph. D. Student 17 12%
Student > Master 17 12%
Student > Doctoral Student 11 8%
Other 26 19%
Unknown 28 20%
Readers by discipline Count As %
Medicine and Dentistry 36 26%
Psychology 29 21%
Nursing and Health Professions 9 7%
Agricultural and Biological Sciences 8 6%
Social Sciences 8 6%
Other 17 12%
Unknown 31 22%